Alzheimer disease: trials for referral
897 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 897 open trials.
No phase1 site
Not yet recruitingChina
NCT07926438
40 Hz Audio-Visual Stimulation Therapy for AD
The First Affiliated Hospital of Xiamen University
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
RecruitingUnited States
NCT07721467
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
National Institute on Aging (NIA)
Registry updated 9 Nov 2026
Registry record: ClinicalTrials.govPhase 3154 sites
RecruitingArgentina, Bulgaria, Brazil, Canada, China, Spain
NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Bristol-Myers Squibb
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 235 sites
RecruitingAustralia, Canada, China, Germany, Spain, United Kingdom
NCT07688213
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Sanofi
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 2/353 sites
RecruitingCanada, Czechia, Germany, Spain, United Kingdom, Italy
NCT07284472
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Exciva GmbH
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingUnited States
NCT06930560
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
Johns Hopkins University
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 372 sites
RecruitingArgentina, Australia, Brazil, Canada, Chile, China
NCT07717411
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Hoffmann-La Roche
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 38 sites
RecruitingCanada
NCT04516057
Nabilone for Agitation Blinded Intervention Trial
Sunnybrook Health Sciences Centre
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 247 sites
RecruitingAustralia, Belgium, Germany, Denmark, Spain, France
NCT07781657
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Hoffmann-La Roche
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT07651319
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
The Methodist Hospital Research Institute
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govNo phase2 sites
RecruitingItaly
NCT07839650
Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training in Alzheimer's Disease
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 119 sites
RecruitingChina, Japan, United States
NCT07787169
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Eli Lilly and Company
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 25 sites
RecruitingUnited States
NCT07873463
Flutemetamol F 18 Injection Formulation Comparison
GE Healthcare
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 2/3155 sites
RecruitingBulgaria, Brazil, Chile, Czechia, Spain, France
NCT06159673
ACP-204 in Adults With Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Registry updated 5 Nov 2026 · The registries disagree on the status
Registry record: ClinicalTrials.govPhase 116 sites
RecruitingAustralia, New Zealand, Singapore, United States
NCT07598370
A Study of LY3439539 in Participants With Alzheimer's Disease
Eli Lilly and Company
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 272 sites
RecruitingJapan, South Korea, Taiwan, United States
NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Eli Lilly and Company
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 3106 sites
By invitation onlyBulgaria, Brazil, Chile, Czechia, Spain, France
NCT06194799
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
ACADIA Pharmaceuticals Inc.
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingItaly
NCT07066137
Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices
IRCCS Centro Neurolesi Bonino Pulejo
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 270 sites
RecruitingBulgaria, Czechia, Spain, Croatia, Romania, Serbia
NCT06651567
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3137 sites
RecruitingArgentina, Chile, Czechia, Germany, France, United Kingdom
NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Bristol-Myers Squibb
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 271 sites
RecruitingBulgaria, Czechia, Spain, Croatia, Italy, Poland
NCT06540833
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Intra-Cellular Therapies, Inc.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase0 sites
Not yet recruiting
NCT07911826
Targeting Sleep and Slow-Wave Activity to Enhance Cognition in MCI
New York State Psychiatric Institute
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 10 sites
Not yet recruiting
NCT07897708
A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults
Pfizer
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govPhase 11 site
RecruitingUnited States
NCT07413744
The Gut - PRO Study
University of Wisconsin, Madison
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govPhase 30 sites
Not yet recruiting
NCT05809908
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
Cerecin
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingChina
NCT07905352
A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's Disease
Vigonvita Life Sciences
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 12 sites
RecruitingUnited States
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
Voyager Therapeutics
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 110 sites
RecruitingUnited Kingdom, Japan, United States
NCT06297590
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Eli Lilly and Company
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 362 sites
RecruitingJapan, Puerto Rico, United States
NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
By invitation onlyUnited States
NCT07600320
Fareon Open Label Device Clinical Trial
Icahn School of Medicine at Mount Sinai
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- United States172 open trials
- China66 open trials
- Canada42 open trials
- Italy36 open trials
- Spain34 open trials
- France29 open trials
- South Korea26 open trials
- United Kingdom25 open trials
- Japan19 open trials
- Taiwan19 open trials
- Germany18 open trials
- Australia18 open trials
- Argentina16 open trials
- Poland16 open trials
- Czechia16 open trials
- Brazil13 open trials
- Netherlands12 open trials
- Bulgaria11 open trials
- Romania11 open trials
- Mexico9 open trials
- Slovakia9 open trials
- Chile9 open trials
- Croatia8 open trials
- Belgium8 open trials
- Serbia8 open trials
- Portugal7 open trials
- Greece7 open trials
- Hungary7 open trials
- Puerto Rico7 open trials
- India6 open trials
- Israel6 open trials
- New Zealand4 open trials
- Ukraine4 open trials
- Türkiye4 open trials
- Finland4 open trials
- Colombia4 open trials
- Norway4 open trials
- Switzerland4 open trials
- Ireland3 open trials
- Denmark3 open trials
- Singapore3 open trials
- Peru2 open trials
- United Arab Emirates2 open trials
- Austria2 open trials
- Sweden2 open trials
- Hong Kong2 open trials
- Russia1 open trial
- Cyprus1 open trial
- Egypt1 open trial
- Saudi Arabia1 open trial
- Jordan1 open trial
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Amsterdam UMC Location Vrije Universiteit Amsterdam
Amsterdam, Netherlands
1 trial · 241 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
Phase changed: No phase → Phase 4
Digital Detection of Dementia (D Cubed) Studies: D2
NCT05231954 · Phase 4 · United States
Source: ClinicalTrials.govNew in the registry
Acoustic Stimulation During Sleep for Alzheimer's Disease
NCT07924657 · No phase · China
Source: ClinicalTrials.govNew in the registry
40 Hz Audio-Visual Stimulation Therapy for AD
NCT07926438 · No phase · China
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
Pharmacokinetics of NTRX-07 in fed and fasted participants
2025-523695-23-00 · Phase 1 · Hungary
Source: EU CTISClosed for recruitment
Prediction of Effectiveness of rTMS Application in Alzheimer's Patients
NCT05977088 · No phase · Türkiye
Source: ClinicalTrials.govOpened for recruitment
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
NCT07781657 · Phase 2 · Australia, Belgium, Germany, Denmark, Spain, France
Source: ClinicalTrials.govClosed for recruitment
Pharmacokinetics of NTRX-07 in fed and fasted participants
2025-523695-23-00 · Phase 1 · Hungary
Source: EU CTISOpened for recruitment
Flutemetamol F 18 Injection Formulation Comparison
NCT07873463 · Phase 2 · United States
Source: ClinicalTrials.govNew in the registry
Music Listening for Chronic Pain in Adults With Early-Stage Dementia
NCT07918534 · No phase
Source: ClinicalTrials.govClosed for recruitment
Obstructive Sleep Apnea and Biomarkers of Alzheimer's Disease
NCT04905238 · No phase · Spain
Source: ClinicalTrials.govNew in the registry
Exercise in Alzheimer's Disease: Functional Biomarkers
NCT07918417 · No phase · Spain
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
NCT07781657 · Phase 2 · Australia, Belgium, Germany, Denmark, Spain, France
Source: ClinicalTrials.govPhase changed: Phase 1 → Phase 1/2
Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease
NCT07367815 · Phase 1/2 · France
Source: ClinicalTrials.govStatus changed: Recruiting → By invitation only
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
NCT07459660 · Phase 2 · Bulgaria, Czechia, France, Hungary, Italy, Poland
Source: ClinicalTrials.govClosed for recruitment
NCT07234942 · Phase 1 · Canada, Spain, United Kingdom, Netherlands, Poland, Sweden
Source: ClinicalTrials.govClosed for recruitment
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578 · Phase 3 · Argentina, Brazil, Canada, China, Germany, Denmark
Source: ClinicalTrials.govClosed for recruitment
A Study of NTRX-07 in Participants With Alzheimer's Disease
NCT07058688 · Phase 2 · Czechia, Hungary, Poland
Source: ClinicalTrials.govPhase changed: Phase 2 → Phase 1/2
NCT06995573 · Phase 1/2 · Austria, Czechia, Germany, Italy
Source: ClinicalTrials.gov
Show more
Phase changed: Phase 1 → Early Phase 1
[18F]ACI-19626 PET in TDP-43 Proteinopathies
NCT06891716 · Early Phase 1 · Netherlands
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
NCT06384573 · Phase 3 · Australia, France, United Kingdom, United States
Source: ClinicalTrials.govPhase changed: Phase 4 → Phase 3
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
NCT06384573 · Phase 3 · Australia, France, United Kingdom, United States
Source: ClinicalTrials.govOpened for recruitment
NCT06126224 · Phase 3 · Belgium, Canada, Switzerland, Chile, China, United Kingdom
Source: ClinicalTrials.govOpened for recruitment
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673 · Phase 2/3 · Bulgaria, Brazil, Chile, Czechia, Spain, France
Source: ClinicalTrials.govPhase changed: Phase 2 → Phase 2/3
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673 · Phase 2/3 · Bulgaria, Brazil, Chile, Czechia, Spain, France
Source: ClinicalTrials.govOpened for recruitment
NCT05980949 · Phase 3 · Argentina, Belgium, Bulgaria, Brazil, Canada, Chile
Source: ClinicalTrials.govPhase changed: Phase 2 → Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511 · Phase 3 · Australia, Canada, Czechia, United Kingdom, Japan, Netherlands
Source: ClinicalTrials.govStatus changed: Completed → Running, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511 · Phase 3 · Australia, Canada, Czechia, United Kingdom, Japan, Netherlands
Source: ClinicalTrials.govOpened for recruitment
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NCT04150198 · Phase 2/3 · France
Source: ClinicalTrials.govClosed for recruitment
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673 · Phase 2/3 · Bulgaria, Brazil, Chile, Czechia, Spain, France
Source: ClinicalTrials.govClosed for recruitment
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease
2024-516966-12-00 · Phase 2 · Czechia, Germany, Spain, France, Italy, Netherlands
Source: EU CTISClosed for recruitment
NCT05980949 · Phase 3 · Argentina, Belgium, Bulgaria, Brazil, Canada, Chile
Source: ClinicalTrials.govClosed for recruitment
NCT06126224 · Phase 3 · Belgium, Canada, Switzerland, Chile, China, United Kingdom
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NCT04150198 · Phase 2/3 · France
Source: ClinicalTrials.govOpened for recruitment
A Study of NTRX-07 in Participants With Alzheimer's Disease
NCT07058688 · Phase 2 · Czechia, Hungary, Poland
Source: ClinicalTrials.govOpened for recruitment
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578 · Phase 3 · Argentina, Brazil, Canada, China, Germany, Denmark
Source: ClinicalTrials.govOpened for recruitment
NCT07234942 · Phase 1 · Canada, Spain, United Kingdom, Netherlands, Poland, Sweden
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
Study of AV-1959D, an Amyloid Beta Vaccine
NCT05642429 · Phase 1 · United States
Source: ClinicalTrials.govClosed for recruitment
Biomarkers for Monitoring Dementia Progression
NCT06855368 · No phase · Italy
Source: ClinicalTrials.gov
New reviews, guidelines and randomised trials in PubMed
Randomised trial
Molecular neurodegeneration · PubMed
Systematic review
Impact of Particulate Matter Exposure on Neurological Health in Older Adults: A Systematic Review.
Current environmental health reports · PubMed
Systematic review
Frontiers in nutrition · PubMed
Meta-analysis
Alzheimer's & dementia : the journal of the Alzheimer's Association · PubMed
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
Phase 3Ended Oct 2026
Paused2046 participants
NCT04520412
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease
Reason given: The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.
No phaseEnded 29 Oct 2026
Completed73404 participants
NCT07399288
Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk
No phaseEnded 10 Oct 2026
Completed43 participants
NCT07388186
Benefits of Strength Training in Informal Caregivers of Patients With Alzheimer's Disease
Phase 2Ended 9 Oct 2026
Completed167 participants
2024-516966-12-00
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease
No phaseEnded 1 Oct 2026
Withdrawn before start0 participants
NCT06391853
Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study
Reason given: Not realisable on time planned and with the academic funds
No phaseEnded 30 Sept 2026
No phaseEnded 16 Sept 2026
No phaseEnded 10 Sept 2026
Completed200 participants
NCT05655793
The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis
No phaseEnded 3 Sept 2026
Stopped early17 participants
NCT04701957
The Ketogenic Diet for Alzheimer's Disease
Reason given: lake of inclusions
Phase 2Ended 1 Sept 2026
Completed260 participants
NCT06881836
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
No phaseEnded 31 Aug 2026
Paused400 participants
NCT03900273
Development of Novel Measures for Alzheimer's Disease Prevention Trials
Reason given: The NYSPI site is currently paused and has been paused since an institutional pause on human subjects research began in June 2023. The U.S. Department of HHS Office of Human Research Protections (OHRP) issued a pause on human subjects research.
No phaseEnded 30 Aug 2026
Completed40 participants
NCT07600996
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease
No phaseEnded 27 Aug 2026
Completed10 participants
NCT06940687
Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers
No phaseEnded 25 Aug 2026
No phaseEnded 25 Aug 2026
Completed126 participants
NCT04908358
The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive Performance
No phaseEnded 18 Aug 2026
Stopped early1 participant
NCT06523296
Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.
Reason given: recruitment challenges
No phaseEnded 17 Aug 2026
Completed673 participants
NCT05637801
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Phase 1Ended 12 Aug 2026
No phaseEnded 29 Jul 2026
Phase 2Ended 25 Jul 2026
Completed86 participants
NCT03649724
The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
Show more
Phase 2Ended 21 Jul 2026
No phaseEnded 9 Jul 2026
Completed32 participants
NCT07174869
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
Phase 1Ended 9 Jul 2026
Completed123 participants
2025-522368-34-00
A study investigating the safety, tolerability, pharmacokinetics (absorption, distribution, metabolism and elimination) and effect of single and multiple doses of MTX46943, a new compound that may potentially be used in the treatment of Alzheimer’s disease and other neurological disorders
No phaseEnded 6 Jul 2026
No phaseEnded 6 Jul 2026
Completed60 participants
NCT07615647
How Video Game Therapy Affects Thinking and Emotions in Older Adults With Cognitive Impairment
No phaseEnded 5 Jul 2026
Completed41 participants
NCT07054385
I-CARE Rural Pilot: Intervention for Rural-Dwelling Dementia Caregivers
Phase 2Ended 2 Jul 2026
Completed304 participants
NCT06182085
Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Phase 2Ended 2 Jul 2026
Completed339 participants
2022-503148-41-00
Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alzheimer’s disease (AD)
No phaseEnded 1 Jul 2026
Completed53 participants
NCT06708182
SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden
Early Phase 1Ended 30 Jun 2026
Completed99 participants
NCT05138848
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease
No phaseEnded 30 Jun 2026
Completed30 participants
NCT04042532
Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia
No phaseEnded 30 Jun 2026
Completed24 participants
NCT07279103
Multisensory Environment-Based Occupational Therapy for Alzheimer's Patients
Phase 2Ended 30 Jun 2026
Completed168 participants
NCT04018092
The Revitalize Study in Older Adults at Risk for Alzheimer's Disease
Phase 4Ended 30 Jun 2026
Completed121 participants
NCT04296565
Water-based Activity to Enhance Recall in Veterans: A Randomized Clinical Trial
Phase 1Ended 25 Jun 2026
Completed7 participants
NCT05667649
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Phase 1Ended 25 Jun 2026
Completed152 participants
NCT06206824
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
No phaseEnded 24 Jun 2026
Withdrawn before start0 participants
NCT07677865
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Reason given: poor accrual and funding issues
No phaseEnded 31 May 2026
No phaseEnded 31 May 2026
No phaseEnded 31 May 2026
Phase 2Ended 28 May 2026
No phaseEnded 26 May 2026
No phaseEnded 26 May 2026
Completed100 participants
NCT06801912
A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD
No phaseEnded 21 May 2026
Completed102 participants
NCT05584241
Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure
Phase 2Ended 20 May 2026
Completed250 participants
NCT05574400
The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study
No phaseEnded 16 May 2026
Completed44 participants
NCT04865172
ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
No phaseEnded 15 May 2026
Completed100 participants
NCT06803797
BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD
Phase 3Ended 12 May 2026
Completed1667 participants
NCT05463731
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Phase 2Ended 11 May 2026
Completed304 participants
NCT06538116
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
No phaseEnded 7 May 2026
Completed26 participants
NCT06202872
Memory Enhancement Using Transcranial Alternating Current Stimulation
Phase 2Ended 6 May 2026
Completed7 participants
NCT06745583
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
No phaseEnded 1 May 2026
No phaseEnded 1 May 2026
No phaseEnded 1 May 2026
Completed9 participants
NCT06055322
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
Phase 1/2Ended 30 Apr 2026
No phaseEnded 30 Apr 2026
Completed634 participants
NCT03403257
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
Phase 4Ended Apr 2026
Withdrawn before start0 participants
NCT06169826
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
Reason given: withdrawn by the PI
No phaseEnded 30 Apr 2026
No phaseEnded 30 Apr 2026
Phase 2Ended 29 Apr 2026
Completed140 participants
NCT06079190
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Not medical advice. fetched 11 Nov 2026